The impact of neutrophil-lymphocyte ratio on risk reclassification of patients with advanced renal cell cancer to guide risk-directed therapy

Angelina Tjokrowidjaja^*, David Goldstein, H. Malcolm Hudson, Sarah J. Lord, Val Gebski, Stephen Clarke, Paul de Souza, Robert J. Motzer, Chee Khoon Lee

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review